Met Life Investment Management, LLC Amicus Therapeutics, Inc. Transaction History
Met Life Investment Management, LLC
- $18 Billion
- Q4 2024
A detailed history of Met Life Investment Management, LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 179,555 shares of FOLD stock, worth $1.24 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
179,555
Previous 169,499
5.93%
Holding current value
$1.24 Million
Previous $1.81 Million
6.57%
% of portfolio
0.01%
Previous 0.01%
Shares
48 transactions
Others Institutions Holding FOLD
# of Institutions
306Shares Held
283MCall Options Held
467KPut Options Held
515K-
Vanguard Group Inc Valley Forge, PA29.3MShares$202 Million0.0% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$168 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY24.2MShares$168 Million7.62% of portfolio
-
Avoro Capital Advisors LLC New York, NY23.2MShares$160 Million3.18% of portfolio
-
William Blair Investment Management, LLC Chicago, IL15.6MShares$108 Million0.38% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $1.94B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...